Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy

Lung stereotactic ablative radiotherapy (SABR) has recently become more common in the management of patients with early-stage non-small cell lung cancer (NSCLC) and metastatic lung lesions who are not surgical candidates. By design, SABR is applied to small treatment volumes, using fewer but signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Stauder, Michael C, Rooney, Jessica W, Neben-Wittich, Michelle A, Garces, Yolanda I, Olivier, Kenneth R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707780/
https://www.ncbi.nlm.nih.gov/pubmed/23829565
http://dx.doi.org/10.1186/1748-717X-8-167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707780/
https://www.ncbi.nlm.nih.gov/pubmed/23829565
http://dx.doi.org/10.1186/1748-717X-8-167

Ejemplares similares